Medasense Biometrics Ltd.
Medasense develops innovative medical devices and applications in the field of objective pain monitoring.
Medasense is led by experienced industry professionals and an international scientific advisory board of key opinion leaders and medical experts.
Following extensive multidisciplinary research, the company has developed a novel index that quantifies the physiological response to pain.
Considering the multifaceted nature of pain, Medasense solution focuses on the body’s physiological “integrated” response to pain, rather than individual pain pathways. Medasense achieves this complex task by analyzing dozens of parameters derived from 4 sensors.
The analysis is done through advanced signal processing. A pain pattern or “signature of pain” is identified and quantified using machine learning algorithms, to deliver a reliable and robust pain index.
The breakthrough NOL™ (Nociception level) index technology paves the way for precision medicine, allowing for personalized and optimized pain care.